GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
CD44 | 1681 | LTM | Head and Neck Cancer | NA | QLL-1 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 1 | 32327629
|
CD24 | 1645 | LTM | Head and Neck Cancer | NA | QLL-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.456 | 32327629
|
MSI1 | 7330 | LTM | Head and Neck Cancer | NA | QLL-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0201 | 32327629
|
MYC | 7553 | LTM | Head and Neck Cancer | NA | QLL-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 32327629
|
NANOG | 20857 | LTM | Head and Neck Cancer | NA | QLL-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 32327629
|
POU5F1 | 9221 | LTM | Head and Neck Cancer | NA | QLL-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 32327629
|
PROM1 | 9454 | LTM | Head and Neck Cancer | NA | QLL-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.7582 | 32327629
|
SOX2 | 11195 | LTM | Head and Neck Cancer | NA | QLL-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5695 | 32327629
|